Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
150 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | Diagnostics | $48.53B | $336.71 | −0.12% | +30.49% |
| 0KSX.L | Quest Diagnostics Incorporated | Diagnostics | $27.60B | $243.72 | −3.24% | +0.48% |
| LH | Labcorp Holdings Inc. | Diagnostics | $27.39B | $337.68 | −0.61% | +12.12% |
| 0JSY.L | Labcorp Holdings Inc. | Diagnostics |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| $27.37B |
| $334.61 |
| −1.30% |
| +1.86% |
| DGX | Quest Diagnostics Incorporated | Diagnostics | $26.99B | $244.51 | −0.61% | +5.46% |
| GH | Guardant Health, Inc. | Diagnostics | $21.90B | $164.92 | −6.60% | +13.37% |
| ERF.PA | Eurofins Scientific SE | Diagnostics | $14.91B | 73.26 EUR | −1.43% | +6.92% |
| ESF0.DE | Eurofins Scientific SE | Diagnostics | $14.63B | 72.70 EUR | −0.82% | +6.29% |
| TEM | Tempus AI, Inc. | Diagnostics | $12.40B | $68.73 | −34.12% | +60.17% |
| BIM.PA | bioMérieux S.A. | Diagnostics | $10.40B | 74.35 EUR | −41.78% | −0.80% |
| QGEN | Qiagen N.V. | Diagnostics | $9.01B | $43.65 | −24.51% | +6.26% |
| QIA.DE | Qiagen N.V. | Diagnostics | $8.85B | 36.41 EUR | −23.51% | −0.78% |
| ALQ.AX | ALS Limited | Diagnostics | $8.23B | 22.52 AUD | −13.95% | +3.21% |
| 6869.T | Sysmex Corporation | Diagnostics | $7.42B | 1,957.00 JPY | −2.76% | +19.66% |
| CAI | Caris Life Sciences, Inc. | Diagnostics | $7.38B | $28.01 | −34.09% | +79.21% |
| SHL.AX | Sonic Healthcare Limited | Diagnostics | $7.20B | 20.31 AUD | −21.28% | −7.72% |
| BLLN | BillionToOne, Inc. | Diagnostics | $4.72B | $100.08 | −33.48% | −21.80% |
| ADPT | Adaptive Biotechnologies Corporation | Diagnostics | $4.19B | $26.25 | −0.91% | +16.46% |
| GRAL | GRAIL, Inc. | Diagnostics | $3.69B | $82.54 | −30.55% | +23.62% |
| VCYT | Veracyte, Inc. Common Stock | Diagnostics | $3.54B | $44.04 | −27.70% | −20.81% |
| CDNA | CareDx, Inc. | Diagnostics | $2.63B | $50.80 | −0.64% | +39.71% |
| WGS | GeneDx Holdings Corp. | Diagnostics | $2.61B | $87.41 | −48.85% | +44.38% |
| NEOG | Neogen Corporation | Diagnostics | $2.54B | $11.64 | −9.42% | +24.63% |
| NEO | NeoGenomics, Inc. | Diagnostics | $2.19B | $16.79 | −1.70% | +27.78% |
| ALIF-B.ST | AddLife AB (publ) | Diagnostics | $2.09B | 162.40 SEK | −22.07% | +0.74% |
| PSNL | Personalis, Inc. | Diagnostics | $1.84B | $17.25 | −8.68% | +43.99% |
| DIA.WA | Diagnostyka S.A. | Diagnostics | $1.54B | 166.50 PLN | −24.28% | +0.54% |
| 4544.T | H.U. Group Holdings, Inc. | Diagnostics | $1.26B | 3,678.00 JPY | −10.14% | +5.93% |
| OPK | OPKO Health, Inc. | Diagnostics | $1.11B | $1.49 | −13.87% | +20.16% |
| QDEL | QuidelOrtho Corporation | Diagnostics | $1.03B | $15.05 | −57.70% | −10.58% |
| CSTL | Castle Biosciences, Inc. | Diagnostics | $1.02B | $35.00 | −20.96% | +43.21% |
| 4694.T | BML, Inc. | Diagnostics | $862.01M | 3,670.00 JPY | −16.31% | +1.66% |
| IDX.AX | Integral Diagnostics Limited | Diagnostics | $638.89M | 2.40 AUD | −21.82% | +15.38% |
| DASA3.SA | Diagnósticos da América S.A. | Diagnostics | $636.08M | 2.62 BRL | −45.07% | −8.07% |
| FLGT | Fulgent Genetics, Inc. | Diagnostics | $548.93M | $19.95 | −35.73% | +1.89% |
| 137310.KS | SD Biosensor, Inc. | Diagnostics | $536.97M | 6,260.00 KRW | −42.73% | +2.45% |
| 4549.T | Eiken Chemical Co., Ltd. | Diagnostics | $486.14M | 2,349.00 JPY | −32.89% | −4.59% |
| CEVI.ST | CellaVision AB (publ) | Diagnostics | $413.78M | 167.40 SEK | −12.90% | +15.93% |
| ACL.AX | Australian Clinical Labs Limited | Diagnostics | $386.24M | 2.89 AUD | −4.46% | +20.42% |
| VOX.WA | Voxel S.A. | Diagnostics | $382.56M | 130.40 PLN | −25.91% | +2.68% |
| NIOX.L | NIOX Group Plc | Diagnostics | $382.51M | 68.00 GBP | −12.37% | +11.48% |
| 0K3W.L | Myriad Genetics, Inc. | Diagnostics | $370.48M | $3.15 | −63.28% | +2.95% |
| N3B.F | Anbio Biotechnology | Diagnostics | $356.84M | 5.50 EUR | −86.78% | −36.78% |
| NNNN | Anbio Biotechnology | Diagnostics | $343.67M | $7.83 | −85.63% | −23.08% |
| 0KCC.L | Insight Molecular Diagnostics Inc. | Diagnostics | $339.65M | $4.42 | −43.11% | +2.67% |
| 197A.T | TAUNS LABORATORIES INC. | Diagnostics | $337.20M | 503.00 JPY | −15.32% | +6.34% |
| YDES | YD Bio Ltd | Diagnostics | $331.49M | $4.68 | −81.28% | +104.37% |
| SBS.DE | Stratec SE | Diagnostics | $324.34M | 22.35 EUR | −32.48% | +7.97% |
| IDHC.L | Integrated Diagnostics Holdings plc | Diagnostics | $317.40M | $0.55 | −34.61% | −0.73% |
| BDSX | Biodesix, Inc. | Diagnostics | $296.22M | $28.08 | −6.42% | +26.35% |
| MYGN | Myriad Genetics, Inc. | Diagnostics | $291.73M | $3.19 | −62.86% | −41.47% |
| 0RAR.L | Stratec SE | Diagnostics | $275.63M | 23.05 EUR | −29.83% | +2.67% |
| OSUR | OraSure Technologies, Inc. | Diagnostics | $260.70M | $3.78 | −17.47% | −4.55% |
| ALERS.PA | Eurobio Scientific Société anonyme | Diagnostics | $232.78M | 20.50 EUR | −20.23% | −3.76% |
| HLS.AX | Healius Limited | Diagnostics | $224.62M | 0.43 AUD | −59.63% | +23.43% |
| 4595.T | Mizuho Medy Co.,Ltd. | Diagnostics | $207.18M | 1,732.00 JPY | −10.26% | +3.34% |
| LUCD | Lucid Diagnostics Inc. | Diagnostics | $190.95M | $1.01 | −38.00% | +11.85% |
| XGN | Exagen Inc. | Diagnostics | $184.11M | $7.60 | −37.86% | +72.73% |
| PEB.AX | Pacific Edge Limited | Diagnostics | $182.42M | 0.21 AUD | −22.64% | −6.82% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | Diagnostics | $179.10M | 2,862.00 JPY | −0.80% | +5.84% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.